Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02630368
Title A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (METROmaJX)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institut Bergonié
Indications

triple-receptor negative breast cancer

Her2-receptor negative breast cancer

Advanced Solid Tumor

sarcoma

Therapies

Avelumab + Cyclophosphamide + JX-594

Cyclophosphamide + JX-594

Cyclophosphamide

Age Groups: adult | senior
Covered Countries


No variant requirements are available.